Advertisement

Topics

Targos Molecular Pathology GmbH Company Profile

02:09 EDT 19th July 2018 | BioPortfolio

"Targos focuses on the application, discovery and development of predictive biomarkers in oncology. Targeted therapies in oncology usually require biomarker guidance in development and clinical application for ethical, economic and regulatory reasons. Targos combines molecular pathology expertise with highly standardized analytics and applies strict project and quality management to provide the international pharma and diagnostic industry with customer-oriented premier biomarker services. In addition, Targos is active in the definition of proprietary biomarkers."

Location

Germany


News Articles [886 Associated News Articles listed on BioPortfolio]

Deploying Digital Pathology in the Autopsy Service Before Surgical Pathology

I believe that most pathology teaching programs in the U.S. will be feeling a need to launch a digital pathology program soon because pathology house officer and fellow candidates are favoring those p...

BioNTech Announces Results from Two More Studies Demonstrating the Benefits of Breast Cancer Subtyping Using Mammatyper®

MammaTyper® is superior to local immunohistochemistry (IHC) for measuring local gene expression in order to predict Oncotype DX®-type results(1) Use of MammaTyper® subtyping for prognosis of brea...

Updated guideline for molecular testing and targeted therapies in lung cancer

(Brigham and Women's Hospital) A panel of leading experts in molecular pathology has issued new recommendations and updates to guidelines for molecular diagnostic testing of patients with lung cancer....

[Comment] Pathology and laboratory medicine: the Cinderella of health systems

High-quality pathology and laboratory medicine (PALM) services are an integral part of health systems in high-income countries. New molecular diagnostic techniques, advances in precision cancer treatm...

Molecular classification in brain tumours

Dr Gilbert talks to ecancer at the Cancer Research UK Brain Tumour Conference 2018 in London about the use of molecular classification in brain tumours and whether classical pathology supersedes it. ...

Experts issue updated guidelines for molecular diagnostic testing of patients with lung cancer

A panel of leading experts in molecular pathology has issued new recommendations and updates to guidelines for molecular diagnostic testing of patients with lung cancer.

LabCorp, Philips collaborate on digital pathology to enhance efficiency of pathology diagnostics

LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, and Royal Philips, a global leader in health technology, announced a collaboration to further advance...

Inspirata Acquires Omnyx from GE Healthcare, Achieving an End-to-End Solution

The business model of Inspirata is relatively unique compared to other companies connected to digital pathology. The company seeks to enhance the digital pathology workflow of its clients presumably p...

PubMed Articles [1524 Associated PubMed Articles listed on BioPortfolio]

System for Informatics in the Molecular Pathology Laboratory (SIMPL): An Open-Source End-to-End Solution for Next-Generation Sequencing Clinical Data Management.

Next-generation sequencing (NGS) diagnostic assays are increasingly becoming the standard of care in oncology practice. As the scale of an NGS laboratory grows, management of these assays requires org...

An update on the use of immunohistochemistry and molecular pathology in the diagnosis of pre-invasive and malignant lesions in gynecological oncology.

One of the most common challenges in everyday clinical practice of gynecological oncology is to identify the type and the primary origin of a tumor. This is a crucial step in the management, treatment...

Safe transportation of formalin-fixed liquid-free pathology specimens.

Diagnostic pathology activities are largely based on fixation of tissues in 4% formaldehyde, which has recently been re-classified as a carcinogenic compound and banned in several countries. Hospitals...

Cytotechnologists as coinvestigators in anatomical pathology research.

The amount of time available to pathologists with which to perform research is becoming limited due to an increasing manpower shortage in pathology, decreased reimbursement, and increased workload. Th...

HER2 testing of gastro-oesophageal adenocarcinoma: a commentary and guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Committee.

The use of biologics targeted to the human epidermal growth factor receptor 2 (HER2) protein is the latest addition to the armamentarium used to fight advanced gastric or gastro-oesophageal junction a...

Clinical Trials [1946 Associated Clinical Trials listed on BioPortfolio]

Molecular Pathology of Colorectal Cancer: Investigating the Role of Novel Molecular Profiles, microRNA's, and Their Targets in Colorectal Cancer Progression

Molecular pathology of Colorectal Cancer: Investigating the role of novel molecular profiles, microRNA's and their targets in Colorectal Cancer progression

iMarkHD: In Vivo Longitudinal Imaging of HD Pathology

iMarkHD is an innovative clinical imaging study and collaboration between the CHDI Foundation and Professor Marios Politis from King's College London (KCL) designed to assess longitudinal ...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Mutation Analysis of 17α-Hydroxylase

To elucidate the molecular pathology of the 4 families with 17α-hydroxylase/17,20-lyase deficiency.

Mutation Analysis of 17βhydroxysteroid Dehydrogenase 3 Deficiency

To disclose the molecular pathology of our 3 families with 17βHSD3 deficiency.

Companies [1500 Associated Companies listed on BioPortfolio]

Targos Molecular Pathology GmbH

"Targos focuses on the application, discovery and development of predictive biomarkers in oncology. Targeted therapies in oncology usually require biomarker guidance in development and clinical applic...

Lakewood Pathology Associates

Lakewood Pathology Associates (LPA) is a national anatomical pathology company providing comprehensive and dynamic pathology services tailored to the outpatient needs of surgeons of diverse specialtie...

HistoRx, Inc

HistoRx is a bioscience company applying quantitative tools of molecular and cellular biology to develop new tools for pathology.HistoRx has introduced the first tissue-based quantitative molecular as...

The Association for Molecular Pathology (AMP)

The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. Through the efforts of its Bo...

Association for Molecular Pathology (AMP)

The Association for Molecular Pathology (AMP) was founded in 1994 to provide structure and leadership to what was, at the time, the newly‐emerging field of molecular diagnost...

More Information about "Targos Molecular Pathology GmbH" on BioPortfolio

We have published hundreds of Targos Molecular Pathology GmbH news stories on BioPortfolio along with dozens of Targos Molecular Pathology GmbH Clinical Trials and PubMed Articles about Targos Molecular Pathology GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Targos Molecular Pathology GmbH Companies in our database. You can also find out about relevant Targos Molecular Pathology GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record